Osceola Regional Medical Center Establishes A Cardiovascular Clinical Research Site
KISSIMMEE, FL, AUG. 30, 2010 – Osceola Regional Medical Center has signed an agreement with Sarah Cannon Research Institute (SCRI), one of the largest clinical research programs in the nation, to be a major cardiovascular clinical research strategic site.
The agreement will allow the Central Florida Cardiac & Vascular Institute of Osceola Regional Medical Center to expand its cardiovascular research program and offer physicians and patients the opportunity to participate in clinical trials locally.
Osceola Regional Medical Center will initially conduct clinical trials in several different cardiovascular specialties including interventional cardiology, electrophysiology, and cardiac and vascular surgery.
“Osceola Regional Medical Center has a stellar reputation for delivering quality and innovative cardiovascular care in multiple specialty areas,” said Steven V. Manoukian, M.D., F.A.C.C., F.S.C.A.I., director of cardiovascular research for SCRI. “Working with Osceola Regional will help SCRI reach our goal of advancing therapies for patients through our growing cardiovascular clinical research network.”
Osceola Regional Medical Center is a 235-bed acute care hospital in Osceola County, Florida, accredited through the Joint Commission and certified as an Advanced Primary Stroke Center. In addition, The Central Florida Cardiac & Vascular Institute at Osceola Regional Medical Center is the only accredited Chest Pain Center with PCI in Osceola County. It is also the only full-service heart hospital in the region, with a dedicated cardiac care tower, Electrophysiology (EP) Studies Lab and a new, state-of-the-art Cardiovascular Hybrid Operating Room.
“Because of our agreement with SCRI, our patients will have access to the latest advancements in cardiovascular disease therapy,” said Brian Marger, F.A.C.H.E., chief operating officer at Osceola Regional Medical Center. “We look forward to expanding our cardiovascular research through clinical trials, which means we can offer our patients additional cutting-edge treatment options for many conditions.”
As part of the agreement, SCRI will help manage quality assurance and regulatory compliance as well as provide information technology capabilities and support. In addition, the staff will have access to SCRI’s physician experts and clinical research team.